JOURNAL OF MOLECULAR NEUROSCIENCE

Scope & Guideline

Illuminating the Pathways of Neural Processes

Introduction

Immerse yourself in the scholarly insights of JOURNAL OF MOLECULAR NEUROSCIENCE with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN0895-8696
PublisherSPRINGERNATURE
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1989 to 2024
AbbreviationJ MOL NEUROSCI / J. Mol. Neurosci.
Frequency9 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The Journal of Molecular Neuroscience focuses on the molecular mechanisms underlying neurological disorders, the development of novel therapeutic strategies, and the exploration of the biological processes involved in neurodegeneration and neuroprotection. It serves as a platform for disseminating research findings related to molecular neuroscience, with a particular emphasis on translational research and the implications for clinical applications.
  1. Molecular Mechanisms of Neurological Disorders:
    The journal explores the intricate molecular pathways involved in various neurological disorders, including Alzheimer's disease, Parkinson's disease, schizophrenia, and autism spectrum disorders. This encompasses genetic, epigenetic, and signaling pathways that contribute to disease pathology.
  2. Neuroprotection and Neuroregeneration:
    Research articles focus on strategies aimed at protecting neurons from damage and enhancing regeneration following injury. This includes studies on neuroprotective agents, stem cell therapy, and the role of neurotrophic factors in promoting neuronal survival and repair.
  3. Translational Research:
    The journal emphasizes the importance of translating basic scientific discoveries into clinical applications, aiming to bridge the gap between laboratory research and patient care. This includes the development of biomarkers for diagnosis and prognosis, as well as novel therapeutic interventions.
  4. Neuroinflammation and Immune Response:
    Papers often discuss the role of inflammation in neurological diseases, examining how immune responses can exacerbate or mitigate neurodegeneration. This includes studies on microglial activation, cytokine profiles, and the impact of the gut-brain axis.
  5. Psychobiotics and Gut-Brain Axis:
    The journal investigates the relationship between gut microbiota and neurological health, exploring how alterations in gut microbiota composition can influence brain function and behavior through biochemical pathways.
  6. Molecular Imaging and Biomarkers:
    Research in this area focuses on the development and application of imaging techniques and biomarker identification for early diagnosis and monitoring of neurological diseases, facilitating personalized medicine approaches.
The Journal of Molecular Neuroscience has recently highlighted several emerging themes that reflect the evolving landscape of research in molecular neuroscience. These trends signify a shift towards more integrative and interdisciplinary approaches to understanding neurological disorders.
  1. Multi-Omics Approaches:
    There is a growing trend in utilizing multi-omics approaches, integrating genomics, proteomics, and metabolomics to gain comprehensive insights into the molecular underpinnings of neurological diseases. This trend allows researchers to identify complex interactions and potential biomarkers for diagnosis and treatment.
  2. Role of Non-Coding RNAs:
    The investigation of non-coding RNAs, such as microRNAs and long non-coding RNAs, has gained prominence. Research is increasingly focusing on their regulatory roles in gene expression and their potential as therapeutic targets or biomarkers in various neurological conditions.
  3. Neuroinflammation as a Therapeutic Target:
    Research emphasizing the role of neuroinflammation in the pathogenesis of neurological disorders is on the rise. Studies are exploring how modulating immune responses can lead to neuroprotection and improved outcomes in conditions like Alzheimer's and multiple sclerosis.
  4. Gut-Brain Axis Research:
    The relationship between gut microbiota and neurological health has emerged as a significant area of interest, reflecting a growing understanding of how gut health can influence brain function and behavior. This includes studies on psychobiotics and their effects on mental health.
  5. Advanced Therapeutic Strategies:
    Emerging therapies such as gene therapy, stem cell therapy, and novel pharmacological approaches are increasingly featured. Research is focusing on innovative strategies to promote neuroprotection and regeneration in neurodegenerative diseases.

Declining or Waning

While the Journal of Molecular Neuroscience continues to explore a broad range of topics, certain areas of research have seen a decrease in publication frequency or focus over the years, indicating a potential shift in interest or relevance within the field.
  1. Traditional Pharmacological Approaches:
    There is a noticeable decline in studies focused solely on traditional pharmacological treatments for neurological disorders without considering molecular mechanisms or novel therapeutic strategies. This shift may reflect a growing interest in understanding the underlying biology rather than just treatment efficacy.
  2. Animal Models of Disease Without Genetic Insights:
    Research relying heavily on classical animal models without incorporating genetic or molecular insights has decreased. The trend seems to favor studies that integrate molecular analyses and genetic profiling to provide a more comprehensive understanding of disease mechanisms.
  3. Basic Neuroanatomy Studies:
    Basic studies focusing solely on neuroanatomy without linking findings to molecular or pathological implications appear to be waning, as the field moves towards more integrative approaches that combine anatomy with molecular and functional insights.
  4. Single-Factor Studies:
    There is a trend away from studies that examine the effects of a single factor (e.g., one drug or one gene) in isolation, as the complexity of neurological disorders necessitates a more holistic approach incorporating multiple factors and interactions.

Similar Journals

Translational Neurodegeneration

Advancing the Frontiers of Neurodegenerative Research
Publisher: BMCISSN: 2047-9158Frequency: 1 issue/year

Translational Neurodegeneration, an esteemed journal in the field of neuroscience, is published by BMC and has been an open access platform since 2012, delivering high-quality research from its base in the United Kingdom. With an impressive impact factor reflecting its significant contributions, this journal focuses on critical advancements in cellular and molecular neuroscience, cognitive neuroscience, and clinical neurology, boasting a Q1 ranking across all these categories as of 2023. Researchers and professionals benefit from its extensive reach, characterized by exceptional Scopus rankings that place it in the top percentile of its field. The journal serves as a vital resource for academics and healthcare practitioners alike, aiming to bridge the gap between laboratory discoveries and clinical applications, thereby enhancing understanding and treatment of neurodegenerative diseases. With its commitment to open access, Translational Neurodegeneration ensures that its published research is accessible to a global audience, promoting collaboration and knowledge exchange within the scientific community.

FEBS Journal

Advancing the Frontiers of Biochemical Research
Publisher: WILEYISSN: 1742-464XFrequency: 24 issues/year

FEBS Journal is a prestigious, peer-reviewed publication dedicated to advancing the field of biochemistry, cell biology, and molecular biology. Published by WILEY in the United Kingdom, this journal boasts an impressive impact factor and ranks in the top quartile (Q1) across multiple relevant categories, including Biochemistry, Cell Biology, and Molecular Biology, reflecting its significant contribution to scientific research. With an ISSN of 1742-464X and an E-ISSN of 1742-4658, the FEBS Journal publishes original research and comprehensive reviews that push the boundaries of knowledge and innovation in the biosciences. As a vital resource for researchers, professionals, and students alike, the journal offers Open Access options, ensuring that cutting-edge discoveries are accessible to a broad audience. With a publication history converging from 2005 to the present and a robust emphasis on high-quality scholarly work, the FEBS Journal remains an essential platform for the dissemination of significant findings and advancements in the life sciences.

ASN Neuro

Pioneering Research for a Deeper Understanding of the Nervous System
Publisher: FRONTIERS MEDIA SAISSN: 1759-0914Frequency: 1 issue/year

ASN Neuro is an esteemed academic journal published by Frontiers Media SA, focusing on critical advancements in the fields of neurology and neuroscience. Since its inception in 2009, it has established itself as an Open Access platform dedicated to fostering the dissemination of knowledge and research findings that address the complexities of the nervous system. With an impressive impact factor and consistently ranking in the top quartiles of its categories—Q1 in Neurology (clinical) and Q2 in Neuroscience (miscellaneous)—ASN Neuro is recognized for its high-quality publications that cater to the evolving challenges in clinical neurology and general neuroscience. Currently, it ranks 68th out of 400 journals in Clinical Neurology and 28th out of 113 in General Neuroscience, affirming its reputable position within the academic community. Researchers, professionals, and students alike are encouraged to contribute to and benefit from this impactful journal as it presents a unique opportunity to engage with cutting-edge research, innovative methodologies, and insightful reviews in the ever-evolving landscape of brain science.

Neurochemical Journal

Advancing Insights into Neural Function
Publisher: MAIK NAUKA/INTERPERIODICA/SPRINGERISSN: 1819-7124Frequency: 4 issues/year

Neurochemical Journal, published by MAIK NAUKA/INTERPERIODICA/SPRINGER, focuses on the dynamic and rapidly evolving field of neurochemistry, providing insights into cellular and molecular neuroscience. Despite the discontinuation of its coverage in Scopus, the journal remains a valuable resource for researchers and professionals seeking to explore the biochemical underpinnings of neural function and pathophysiology. With an ISSN of 1819-7124 and an E-ISSN of 1819-7132, the journal aims to publish rigorous research articles, reviews, and notes that push the boundaries of our understanding of neurochemical processes. With a ranking that places its subjects in the lower quartile of their respective fields, Neurochemical Journal offers a platform for innovative studies and discussions among up-and-coming scientists, making it a crucial outlet for advancing the discourse in this critical area of biomedical research.

ACS Chemical Neuroscience

Unraveling the Molecular Mysteries of Neural Function.
Publisher: AMER CHEMICAL SOCISSN: 1948-7193Frequency: 12 issues/year

ACS Chemical Neuroscience, published by the American Chemical Society, is a premier journal dedicated to exploring the complex interactions between chemistry and neuroscience. With its ISSN 1948-7193 and a distinguished impact factor that positions it within the top quartiles across multiple categories, including Q1 in Biochemistry, Q2 in Cell Biology, and Q1 in Physiology, this journal serves as an essential platform for researchers engaged in cutting-edge studies from 2010 to 2024. Positioned within the top 15% of its field in Cognitive Neuroscience according to Scopus rankings, ACS Chemical Neuroscience strives to foster interdisciplinary collaboration, publishing significant advancements that integrate chemical concepts with neurological processes. Despite its traditional publication model, the journal is committed to maintaining rigorous peer-review standards and providing valuable insights that drive innovations in therapeutics and understanding the biochemical underpinnings of brain function. Researchers, professionals, and students alike will find in this journal a vital resource for the latest findings and methodologies in the dynamic intersection of chemistry and neuroscience.

ACTA NEUROBIOLOGIAE EXPERIMENTALIS

Illuminating the Complexities of Medicine and Mind
Publisher: NENCKI INST EXPERIMENTAL BIOLOGYISSN: 0065-1400Frequency: 4 issues/year

ACTA NEUROBIOLOGIAE EXPERIMENTALIS, an esteemed journal published by the Nencki Institute of Experimental Biology in Poland, has been a pivotal platform for the dissemination of research in the fields of medicine and neuroscience since its inception in 1970. With an ISSN of 0065-1400 and an E-ISSN of 1689-0035, this journal has consistently aimed to contribute to the understanding of neurobiological phenomena, cementing its status within the academic community. Despite its current categorization in the Q3 and Q4 quartiles for Medicine and Neuroscience respectively, ACTA NEUROBIOLOGIAE EXPERIMENTALIS continues to uphold rigorous scientific standards, providing an invaluable resource for researchers, professionals, and students alike. As an essential scholarly outlet, it encourages the exploration of groundbreaking findings and clinical applications in neurobiology, making it an attractive choice for those eager to advance their understanding of this intricate field.

EXPERIMENTAL NEUROLOGY

Exploring Innovative Pathways in Developmental Neuroscience.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0014-4886Frequency: 12 issues/year

EXPERIMENTAL NEUROLOGY is a premier academic journal published by Academic Press Inc, Elsevier Science, focusing on advancements in the fields of Developmental Neuroscience and Neurology. With an impressive Impact Factor and ranked in the Q1 quartile of both categories—positioning it among the top-tier journals—this publication has established itself as a vital resource for researchers, clinicians, and students alike. Since its inception in 1959, it has fostered the dissemination of cutting-edge research and innovative approaches to understanding neurological function and related disorders. While EXPERIMENTAL NEUROLOGY currently operates under a subscription access model, its rich archives and ongoing contributions to the field continue to inspire and inform the next generation of neurobiologists. The journal also boasts a high ranking in Scopus, placing fourth in Developmental Neuroscience and twentieth in Neurology, indicating its robust influence and scholarly significance. For those committed to advancing knowledge in these critical areas, EXPERIMENTAL NEUROLOGY is an indispensable platform for inquiry and discovery.

NEUROMOLECULAR MEDICINE

Bridging Molecular Insights and Neurological Innovations
Publisher: HUMANA PRESS INCISSN: 1535-1084Frequency: 4 issues/year

NEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.

SYNAPSE

Pioneering Research in Cellular and Molecular Neuroscience
Publisher: WILEYISSN: 0887-4476Frequency: 12 issues/year

SYNAPSE, an esteemed journal in the field of Cellular and Molecular Neuroscience, is published by Wiley and serves as a vital platform for disseminating groundbreaking research in neuroscience. Established in 1987, this journal has been pivotal in exploring the intricate mechanisms governing synaptic function and neural communication, contributing to our understanding of the nervous system. With an ISSN of 0887-4476 and an E-ISSN of 1098-2396, SYNAPSE is indexed in Scopus and currently holds a Q4 quartile ranking in its category, reflecting its niche yet significant presence within the research community. Despite its recent ranking in the 21st percentile among its peers, the journal’s commitment to quality and innovation remains unwavering. It is published from Hoboken, New Jersey, and although it is not an open-access journal, it provides invaluable insights and critical reviews that are pivotal for researchers, professionals, and students alike who seek to advance their knowledge in the dynamic field of neuroscience. Join us in contributing to the ever-evolving discourse in cellular and molecular neuroscience through SYNAPSE.

Translational Neuroscience

Exploring Innovative Frontiers in Neurological Research.
Publisher: DE GRUYTER POLAND SP Z O OISSN: 2081-3856Frequency: 1 issue/year

Translational Neuroscience, published by DE GRUYTER POLAND SP Z O O, is a leading open-access journal since its inception in 2015, dedicated to the multidisciplinary exploration of neurological research and its clinical applications. With an ISSN of 2081-3856 and an E-ISSN of 2081-6936, the journal serves as a crucial platform for scholars and practitioners to disseminate innovative findings and theoretical advancements in the field of neuroscience. Covering various aspects of general neuroscience, it is ranked in the Q3 quartile for 2023 and positioned at Rank #75 out of 113 in its category, reflecting its growing impact within the scientific community. The journal strives to bridge the gap between laboratory research and clinical practice, fostering collaboration among researchers, clinicians, and educators. The editorial team is committed to maintaining high publication standards that engage the audience with rigorous research while promoting a culture of open science. For those interested in the forefront of neuroscience research, Translational Neuroscience offers an invaluable resource for knowledge and innovation.